Geisinger, Healthy.io Clinical Trial Using Smartphones to Detect Kidney Disease | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Geisinger, Healthy.io Clinical Trial Using Smartphones to Detect Kidney Disease

April 11, 2018
by Heather Landi
| Reprints
Click To View Gallery

The National Kidney Foundation (NKF), Danville, Pa.-based health system Geisinger and Healthy.io have launched a clinical trial using a smartphone-enabled home urinalysis device for chronic kidney disease (CKD) among patients with high blood pressure.

Hypertension, or high blood pressure, is a contributing risk factor to CKD. One of the best ways to test for CKD and assess kidney damage is a simple urine test which detects the presence of albumin. The smartphone app from Healthy.io enables lay users to conduct a urinalysis test at home and securely share results with their clinicians, according to a Geisinger press release.

Healthy.io is a health technology company based in Tel Aviv, Israel that uses computer vision, machine learning and user-centric design to turn the smartphone camera into a clinical-grade medical device.

Approximately 30 million Americans have CKD, but nearly 90 percent do not know they have this condition. CKD progression can be slowed or halted if the disease, which often has no symptoms, is caught in its early stages, according to Geisinger officials.

“Early detection of CKD is crucial so that risk factors can be aggressively managed to prevent end-stage renal disease and cardiovascular disease,” Alexander Chang, M.D., practicing nephrologist and assistant professor in the Kidney Health Research Institute at Geisinger, said in a statement.

“This new trial using a smartphone app and urinalysis kit will provide important information on how to increase testing for CKD in this high-risk population,” Kerry Willis, Ph.D., chief scientific officer, NKF, said. “Our hope is that a home-based test makes it easier for patients at risk for CKD to comply with regular albuminuria screening, and that this will lead to earlier diagnosis and treatment of CKD, reducing cardiovascular risk and preserving kidney function.”  

The new trial will examine the effect of mailed, Healthy.io smartphone urinalysis kits (Dip.io test) to improve albuminuria screening compliance and detection of albuminuria and examine the feasibility of pharmacists in improving management of detected albuminuria, as pharmacists will be instructed to confirm test with urine albumin/creatinine ratio and treat albuminuria. 

What’s more, the clinical trial will also randomize 1,000 non-diabetic patients with hypertension who are receiving primary care at Geisinger. Patients will be randomized into two groups; one group receiving the usual care and one group who will receive a mailed Healthy.io urinalysis kit. A home test will be mailed to 500 Geisinger patients who have been diagnosed with hypertension, but who do not have diabetes, along with instructions for downloading the smartphone app, to determine if the patient also has CKD.

Geisinger patients will receive a letter and phone call educating them on the importance of screening for proteinuria from a team of nurses within the organization’s Care Gaps department. Appropriate follow-up will then be managed by the patient’s primary care provider and care team. 

“Healthy.io is proud to pioneer its 'adherence as a service’ platform with such forward-looking institutions as Geisinger and the National Kidney Foundation,” Yonatan Adiri, Healthy.io CEO, said in a statement. “Our mission is to use advanced computer vision and patient centric design to let clinicians empower their patients at scale without additional cost or effort. Like a Netflix for adherence we lean on the spread of digital technology and efficient logistics to offer on-demand testing delivered directly to the home. With a smartphone in your pocket, the point of care becomes wherever you are.” 

The new clinical trial, which gets underway this month, was announced April 10 at NKF’s 2018 Annual Spring Clinical Meetings held from April 10-14 at the Austin Convention Center, Texas.

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

House Appropriations Bill Includes 29 Percent Budget Cut for ONC, $1.25B Increase for NIH in 2019

The House Appropriations Committee released a draft 2019 budget for the U.S. Department of Health and Human Services (HHS) and departments of Labor and Education that proposed slashing funding for the Office of the National Coordinator for Health IT (ONC) by $17.7 million.

Value-Based Care is Bending the Cost Curve, Report Finds

Value-based care is bending the healthcare cost curve, reducing unnecessary medical costs by nearly 6 percent on average while also improving care quality and patient engagement, according to new research from Nashville-based Change Healthcare.

Health Share of Oregon Facing Challenges with Ride to Care Service

Health Share of Oregon’s non-emergency transportation vendor is in danger of losing money if it doesn’t meet its performance targets by the end of June, the coordinated care organization recently stated.

NJ Hospital Association Invests in Opioid Tracking Tool for Hospitals

As opioid overdoses continue to claim more lives, the New Jersey Hospital Association and its Health Research and Educational Trust announced a $1.5 million investment in an emergency department tracking tool for hospitals statewide to better monitor opioid prescriptions.

Sequoia Project Revises National Patient Matching Framework

The nonprofit Sequoia Project, an industry advocate for nationwide interoperability, has released a revised national patient matching framework.

Kaiser, Emory Healthcare Partner on Integrated Care Model in Atlanta

Emory Healthcare, the clinical arm of Emory University, and Kaiser Permanente have announced a partnership in metropolitan Atlanta.